Assenagon Asset Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.08M Buy
91,875
+47,003
+105% +$2.6M 0.01% 545
2025
Q1
$2.17M Sell
44,872
-7,367
-14% -$356K ﹤0.01% 725
2024
Q4
$2.02M Buy
+52,239
New +$2.02M ﹤0.01% 932